Recall Ledger

SEMAGLUTIDE 2.5mg recall (Apollo Care, LLC)

DrugClass IIOngoing

Summary: Apollo Care, LLC is recalling SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02. Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material.

What is being recalled

SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02

Why

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

Nationwide within the U.S

How to tell if yours is affected

Lot: AC-017271, Exp. 12/12/2026.

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0753-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedJuly 29, 2026
ReportedAugust 19, 2026
CompanyApollo Care, LLC
Company locationColumbia, MO, United States
Initiated byVoluntary: Firm initiated
Quantity250 vials.

More recalls from Apollo Care, LLC · all drug recalls · recalls from July 2026

Official FDA record